SCHEMBL8499734

SCHEMBL8499734

COc1cc2ncc(-c3cccs3)nc2cc1OC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.71
RAB9A P51151 4/20 0.71
PDGFRB P09619 5/20 0.68
PDGFRA P16234 4/20 0.68
RPS6KB2 Q9UBS0 2/20 0.66
ALDH1A1 P00352 4/20 0.60
GAA P10253 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
KDM4E B2RXH2 3/20 0.60
HSD17B10 Q99714 2/20 0.60
HPGD P15428 2/20 0.60
CASP1 P29466 1/20 0.60
MAPK10 P53779 1/20 0.60
CASP7 P55210 1/20 0.60
MAPT P10636 3/20 0.60
GLA P06280 2/20 0.60
HDAC6 Q9UBN7 1/20 0.60
KIT P10721 1/20 0.57
FLT3 P36888 1/20 0.57
IDO1 P14902 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8500124 0.86 NPC1 (0.68) NPC1RAB9APDGFRBPDGFRARPS6KB2
SCHEMBL8501345 0.81 PDGFRB (1.00) PDGFRBPDGFRARPS6KB2
SCHEMBL8500901 0.77 PDGFRB (0.71) NPC1RAB9APDGFRBPDGFRAALDH1A1
SCHEMBL6616540 0.76 NPC1 (0.66) NPC1RAB9APDGFRBPDGFRARPS6KB2
SCHEMBL708998 0.76 NPC1 (1.00) NPC1RAB9APDGFRBPDGFRARPS6KB2
SCHEMBL31393433 0.76 NPC1 (1.00) NPC1RAB9APDGFRBPDGFRARPS6KB2
SCHEMBL8504154 0.75 NPC1 (0.65) NPC1RAB9APDGFRBRPS6KB2ALDH1A1
Hydrochloric Acid SCHEMBL8562915 0.75 PDGFRB (0.69) NPC1RAB9APDGFRBPDGFRAALDH1A1
SCHEMBL595944 0.75 SMN1; SMN2 (1.00) NPC1RAB9APDGFRBPDGFRAALDH1A1
SCHEMBL29351353 0.75 SMN1; SMN2 (1.00) NPC1RAB9APDGFRBPDGFRAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US claimed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US claimed
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed